The Tissue Tranglutaminase Test Industry is expected to grow at a CAGR of ~17.5% during the forecast period.
Increasing prevalence of celiac disease drives the growth of the market. According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe.
Download Free sample copy at https://www.marketresearchfuture.com/sample_request/824
Competitive Analysis:
Some of key players profiled in the report are,
- Quest Diagnostics Incorporated.
- SQI Diagnostics
- Trinity Biotech
- ZEDIRA GmbH
- Demeditec Diagnostics GmbH
- ARUP Laboratories
- Cell Science Systems
- Bio-Rad Laboratories Inc.
- Pfizer Inc.
- Celimmune LLC.
- and others.
Market Segmentation:
The global Tissue Tranglutaminase Testing Industry has been segmented on the basis types and end users.
Based on types, the market has been segmented into serological, biopsy testing, and others. The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and tissue transglutaminase (tTG) antibody- IgG, serum.
Based on the end users, the market has been segmented as hospitals & clinics, homecare, research organizations, and others.
Table Of Contents
Report Prologue
Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Tissue Tranglutaminase Testing Industry, By Type
Serological Testing
Tissue Transglutaminase (TTG) Antibodies, IgA, Serum
Tissue Transglutaminase (TTG) Antibody, IgG, Serum
Others.
…To be Continued
Brows Complete Detailed Research Report at https://www.marketresearchfuture.com/reports/tissue-transglutaminase-test-market-824
Comments
Post a Comment